JSJulia Sjöberg

Julia Sjöberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Sjöberg has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chemotherapy-related anemia is regulated through caspase-1–mediated ROCK1 activation

    by Julia Sjöberg, Anna Rydström, Oscar Hedberg, Tariq Enver, Jonas Larsson, Els Mansell, Valgardur Sigurdsson

    Hematopoietic stem cells (HSCs) have the ability to produce all cells in the blood system and are crucial for blood and immune recovery after chemotherapy. Patients with cancer often experience anemia, especially during chemotherapy treatment. Severe anemia may cause treatment disruption and is closely linked to a worse prognosis for the patient. We followed hematopoietic recovery in mice after chemotherapy treatment with 5-fluorouracil (5-FU) and found that erythrocyte recovery is delayed compared to other blood lineages. The delayed erythroid recovery manifests itself in HSCs that are transcriptionally and functionally biased toward myeloid cell production at the expense of erythropoiesis. We show that this erythroid deficiency is rescued in a caspase-1−/− mouse model, and that caspase-1 regulates lineage bias through an interleukin-1β–independent mechanism involving rho-associated coiled-coil–containing protein kinase 1 (ROCK1). Inhibiting the caspase-1 substrate ROCK1 leads to a rescue of erythropoiesis after 5-FU treatment. Indeed, we confirmed that ROCK1 is cleaved and activated by caspase-1 upon 5-FU treatment, suppressing erythropoiesis. Currently, patients with cancer who are anemic have limited treatment options for improving their red blood cell numbers. Several ROCK1 inhibitors have already been approved for use in other conditions and could potentially be used to mitigate anemia associated with cancer and chemotherapy, thereby improving quality of life and outcomes for patients with cancer.

  • Open Access

    Lipoprotein metabolism mediates hematopoietic stem cell responses under acute anemic conditions

    by Kiyoka Saito, Mark van der Garde, Terumasa Umemoto, Natsumi Miharada, Julia Sjöberg, Valgardur Sigurdsson, Haruki Shirozu, Shunsuke Kamei, Visnja Radulovic, Mitsuyoshi Suzuki, et al.

    Hematopoietic stem cells (HSCs) react to various stress conditions. However, it is unclear whether and how HSCs respond to severe anemia. Here, we demonstrate that upon induction of acute anemia, HSCs rapidly proliferate and enhance their erythroid differentiation potential. In severe anemia, lipoprotein profiles largely change and the concentration of ApoE increases. In HSCs, transcription levels of lipid metabolism-related genes, such as very low-density lipoprotein receptor (Vldlr), are upregulated. Stimulation of HSCs with ApoE enhances their erythroid potential, whereas HSCs in Apoe knockout mice do not respond to anemia induction. VldlrhighHSCs show higher erythroid potential, which is enhanced after acute anemia induction. VldlrhighHSCs are epigenetically distinct because of their low chromatin accessibility, and more chromatin regions are closed upon acute anemia induction. Chromatin regions closed upon acute anemia induction are mainly binding sites of Erg. Inhibition of Erg enhanced the erythroid differentiation potential of HSCs. Our findings indicate that lipoprotein metabolism plays an important role in HSC regulation under severe anemic conditions.